SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-23-007531
Filing Date
2023-03-22
Accepted
2023-03-22 16:10:35
Documents
74
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K atos20221231_10k.htm   iXBRL 10-K 1372134
2 EXHIBIT 10.3 ex_488409.htm EX-10.3 65109
3 EXHIBIT 21.1 LIST OF SUBSIDIARIES ex_455745.htm EX-21.1 1474
4 EXHIBIT 23.1 AUDITORS' CONSENT ex_455746.htm EX-23.1 4292
5 EXHIBIT 31.1 ex_455747.htm EX-31.1 11187
6 EXHIBIT 31.2 ex_455748.htm EX-31.2 11086
7 EXHIBIT 32.1 ex_455749.htm EX-32.1 5848
8 EXHIBIT 32.2 ex_455750.htm EX-32.2 6422
14 cdp01.jpg GRAPHIC 59671
  Complete submission text file 0001437749-23-007531.txt   5964311

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA atos-20221231.xsd EX-101.SCH 56909
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atos-20221231_cal.xml EX-101.CAL 42239
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atos-20221231_def.xml EX-101.DEF 362351
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE atos-20221231_lab.xml EX-101.LAB 338661
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atos-20221231_pre.xml EX-101.PRE 392488
68 EXTRACTED XBRL INSTANCE DOCUMENT atos20221231_10k_htm.xml XML 669462
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35610 | Film No.: 23753029
SIC: 2834 Pharmaceutical Preparations